These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27140191)

  • 1. A New Score for Estimating Survival After Definitive Radiochemotherapy of Limited Disease Small Cell Lung Cancers.
    Rades D; Kaesmann L; Janssen S; Schild SE
    Lung; 2016 Aug; 194(4):625-9. PubMed ID: 27140191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy.
    Käsmann L; Abdo R; Eze C; Dantes M; Taugner J; Gennen K; Roengvoraphoj O; Rades D; Belka C; Manapov F
    Lung; 2020 Feb; 198(1):201-206. PubMed ID: 31897594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Radiation Dose on Survival after Radiochemotherapy for Small-cell Lung Cancer.
    Käsmann L; Janssen S; Schild SE; Rades D
    Anticancer Res; 2016 Mar; 36(3):1089-91. PubMed ID: 26977003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
    Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM
    Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of effectiveness and safety of different treatment modes for limited-stage small cell lung].
    Shen J; Wang LH; Zhang FQ; Wang MZ; Li Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Jun; 35(3):343-7. PubMed ID: 23827076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
    Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoradiotherapy duration correlates with overall survival in limited disease SCLC patients with poor initial performance status who successfully completed multimodality treatment.
    Manapov F; Klöcking S; Niyazi M; Belka C; Hildebrandt G; Fietkau R; Klautke G
    Strahlenther Onkol; 2012 Jan; 188(1):29-34. PubMed ID: 22189436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-to-Lymphocyte Ratio Predicts Outcome in Limited Disease Small-cell Lung Cancer.
    Käsmann L; Bolm L; Schild SE; Janssen S; Rades D
    Lung; 2017 Apr; 195(2):217-224. PubMed ID: 28154994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Factors and Treatment of Early-stage Small-cell Lung Cancer.
    Käsmann L; Bolm L; Janssen S; Rades D
    Anticancer Res; 2017 Mar; 37(3):1535-1537. PubMed ID: 28314330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of Comorbidity Scales for Predicting Survival After Radiochemotherapy of Small Cell Lung Cancer.
    Kaesmann L; Janssen S; Schild SE; Rades D
    Lung; 2016 Apr; 194(2):295-8. PubMed ID: 26883133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Survival Score for Patients Receiving Palliative Irradiation for Locally Advanced Lung Cancer.
    Rades D; Käsmann L; Schild SE; Janssen S
    Clin Lung Cancer; 2016 Nov; 17(6):558-562. PubMed ID: 27341791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis.
    Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Ohe Y; Nishiwaki Y
    J Thorac Oncol; 2011 Apr; 6(4):796-800. PubMed ID: 21258253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response.
    Fujii M; Hotta K; Takigawa N; Hisamoto A; Ichihara E; Tabata M; Tanimoto M; Kiura K
    Lung Cancer; 2012 Oct; 78(1):107-11. PubMed ID: 22858447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined modality therapy for small cell lung cancer patient with limited stage disease].
    Wang HJ; Sun KL; Zhang XR; Sun Y; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):701-3. PubMed ID: 18246803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiation.
    Lee J; Kim JO; Jung CK; Kim YS; Yoo IeR; Choi WH; Jeon EK; Hong SH; Chun SH; Kim SJ; Kim YK; Kang JH
    Clin Lung Cancer; 2014 Mar; 15(2):e13-21. PubMed ID: 24368212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first survival score for patients with brain metastases from small cell lung cancer (SCLC).
    Rades D; Dziggel L; Segedin B; Oblak I; Nagy V; Marita A; Schild SE
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2029-32. PubMed ID: 23871680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of downstaging in patients with limited-disease small-cell lung cancer.
    Go SI; Keam B; Kim TM; Lee SH; Kim DW; Kim HJ; Wu HG; Chung DH; Heo DS
    Clin Lung Cancer; 2014 Mar; 15(2):e1-6. PubMed ID: 24356090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy.
    Roengvoraphoj O; Eze C; Niyazi M; Li M; Hildebrandt G; Fietkau R; Belka C; Manapov F
    Strahlenther Onkol; 2017 Feb; 193(2):150-155. PubMed ID: 27853828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of surgery combined with chemoradiotherapy in treating limited-stage small cell lung cancer and prognosis analysis.
    Gu W; Zhong XLXLY
    J BUON; 2021; 26(3):812-818. PubMed ID: 34268940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of surgical resection for patients with limited disease-small cell lung cancer.
    Takenaka T; Takenoyama M; Inamasu E; Yoshida T; Toyokawa G; Nosaki K; Hirai F; Yamaguchi M; Shimokawa M; Seto T; Ichinose Y
    Lung Cancer; 2015 Apr; 88(1):52-6. PubMed ID: 25662387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.